NAVARRETE RUEDA, FRANCISCO

Person (Active)

Positions

Profesor/a Titular Universidad, Farmacología, Pediatría y Química Orgánica 2023 -
PDI INVESTIGADOR, Instituto de Neurociencias 2022 -
Profesor/a Contratado/a Doctor/a, Farmacología, Pediatría y Química Orgánica 2019 -
MIEMBRO, Neuropsicofarmacología Traslacional 2015 -
Profesor/a Ayudante Doctor/a, Farmacología, Pediatría y Química Orgánica 2014 - 2019
APOYO TECNICO A LA INVESTIGACION A, Ingeniería de Comunicaciones 2013 - 2014
PERSONAL INVESTIGADOR EN FORMACION, Ingeniería de Comunicaciones 2010 - 2012
FPU-MINISTERIO, Instituto de Neurociencias 2008 - 2010
BECARIO/A PREDOCTORAL (INSTITUTOS), Instituto de Neurociencias 2007 - 2009
GRUPO 1: BECAS A ESTUDIANTES DE 1ER Y 2º CICLO, Instituto de Bioingeniería 2007

Publications
Research
Teaching
Service
Contact
Otro
Ver todos

supported publications or other works

selected publications

academic article
- Adolescent intermittent ethanol exposure decreases perineuronal nets in the hippocampus in a sex dependent manner: Modulation through pharmacological inhibition of RPTPß/¿ . NEUROPHARMACOLOGY. 1-11. 2024
- Fetal Cannabinoid Syndrome: Behavioral and Brain Alterations of the Offspring Exposed to Dronabinol during Gestation and Lactation. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 7453-7482. 2024
- Understanding the Biological Relationship between Migraine and Depression. BIOMOLECULES. 1-37. 2024
- Cannabidiol regulates behavioral and brain alterations induced by spontaneous alcohol withdrawal. NEUROPHARMACOLOGY. 109549-109557. 2023
- Cannabidiol repairs behavioral and brain disturbances in a model of fetal alcohol spectrum disorder. PHARMACOLOGICAL RESEARCH. 106655-106676. 2023
- Cognitive Alterations in Addictive Disorders: A Translational Approach. BIOMEDICINES. 1796-1851. 2023
- Emotional Processing and Maltreatment During Childhood as Factors of Vulnerability to Alcohol Abuse in Young Adults. INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION. 1-21. 2023
- Methods to Identify Cognitive Alterations from Animals to Humans: A Translational Approach. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 7653-7686. 2023
- Role of CB2 cannabinoid receptor in the development of food addiction in male mice. NEUROBIOLOGY OF DISEASE. 106034-106048. 2023
- Sex differences in the comorbidity of patients seeking a first treatment for Alcohol Use Disorder. INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION. 1-15. 2023
- Biomarkers of the Endocannabinoid System in Substance Use Disorders.. BIOMOLECULES. 1-47. 2022
- CBD-mediated regulation of heroin withdrawal-induced behavioural and molecular changes in mice. ADDICTION BIOLOGY. 1-11. 2022
- Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders.. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 1-66. 2022
- CB2 Receptor Involvement in the Treatment of Substance Use Disorders. BIOMOLECULES. 1-18. 2021
- Cannabidiol Modulates Behavioural and Gene Expression Alterations Induced by Spontaneous Cocaine Withdrawal. . NEUROTHERAPEUTICS. 615-623. 2021
- Cannabidiol and Sertraline Regulate Behavioral and Brain Gene Expression Alterations in an Animal Model of PTSD. FRONTIERS IN PHARMACOLOGY. 1-14. 2021
- Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice. JOURNAL OF PSYCHOPHARMACOLOGY. 864-874. 2021
- Differences in Gene Expression of Endogenous Opioid Peptide Precursor, Cannabinoid 1 and 2 Receptors and Interleukin Beta in Peripheral Blood Mononuclear Cells of Patients With Refractory Failed Back Surgery Syndrome Treated With Spinal Cord Stimulation: Markers of Therapeutic Outcomes. NEUROMODULATION. 49-60. 2021
- Editorial: Cannabidiol treatment in neurotherapeutic interventions. FRONTIERS IN PHARMACOLOGY. 1-2. 2021
- Editorial: The Search for Biomarkers in Psychiatry. FRONTIERS IN PSYCHIATRY. 720411-720412. 2021
- Relation between Alpha-Synuclein and Core CSF Biomarkers of Alzheimer¿s Disease. MEDICINE. 1-9. 2021
- Role of cannabidiol in therapeutic intervention for substance use disorders. FRONTIERS IN PHARMACOLOGY. 1-24. 2021
- Therapeutic potential of the cannabinoid receptor 2 in neuropsychiatry. EXPLORATION OF NEUROPROTECTIVE THERAPY . 55-71. 2021
- Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality. FRONTIERS IN PSYCHIATRY. 1-14. 2020
- Cannabidiol Modulates Behavioural and Gene Expression Alterations Induced by Spontaneous Cocaine Withdrawal. NEUROTHERAPEUTICS. 2020
- Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders. BIOMOLECULES. 1-34. 2020
- Cannabis Use in Pregnant and Breastfeeding Women: Behavioral and Neurobiological Consequences. FRONTIERS IN PSYCHIATRY. 1-15. 2020
- Differences in Gene Expression of Endogenous Opioid Peptide Precursor, Cannabinoid 1 and 2 Receptors and Interleukin Beta in Peripheral Blood Mononuclear Cells of Patients With Refractory Failed Back Surgery Syndrome Treated With Spinal Cord Stimulation: Markers of Therapeutic Outcomes?. NEUROMODULATION. 2020
- Endocannabinoid System Components as Potential Biomarkers in Psychiatry. FRONTIERS IN PSYCHIATRY. 1-30. 2020
- Neuropsychophysiological Measures of Alcohol Dependence: Can We Use EEG in the Clinical Assessment?. FRONTIERS IN PSYCHIATRY. 1-17. 2020
- Cannabidiol does not display drug abuse potential in mice behavior.. ACTA PHARMACOLOGICA SINICA. 358-364. 2019
- Measurement of CSF alpha-synuclein improves early differential diagnosis of mild cognitive impairment due to Alzheimer's disease.. JOURNAL OF NEUROCHEMISTRY. 218-230. 2019
- Alterations in gene and protein expression of cannabinoid CB2 and GPR55 receptors in the dorsolateral prefrontal cortex of suicide victims. NEUROTHERAPEUTICS. 796-806. 2018
- Cannabidiol does not display drug abuse potential in mice behavior. ACTA PHARMACOLOGICA SINICA. 1-7. 2018
- Cannabidiol reduces ethanol consumption, motivation and relapse in mice. ADDICTION BIOLOGY. 154-164. 2018
- Cannabidiol regulates behavioural alterations and gene expression changes induced by spontaneous cannabinoid withdrawal. BRITISH JOURNAL OF PHARMACOLOGY. 2676-2688. 2018
- Cannabinoid CB1 and CB2 receptors, and monoacylglycerol lipase gene expression alterations in the basal ganglia of patients with Parkinson's disease. NEUROTHERAPEUTICS. 459-469. 2018
- Deletion of Dlk1 increases the vulnerability to developing anxiety-like behaviors and ethanol consumption in mice. BIOCHEMICAL PHARMACOLOGY. 37-44. 2018
- Pharmacological regulation of cannabinoid CB2 receptor modulates the reinforcing and motivational actions of ethanol. BIOCHEMICAL PHARMACOLOGY. 227-234. 2018
- Cannabidiol reduces ethanol consumption, motivation and relapse in mice.. ADDICTION BIOLOGY. 1-11. 2017
- Deletion of Dlk2 increases the vulnerability to anxiety-like behaviors and impairs the anxiolytic action of alprazolam. PSYCHONEUROENDOCRINOLOGY. 134-141. 2017
- Different Molecular/Behavioral Endophenotypes in C57BL/6J Mice Predict the Impact of OX1 Receptor Blockade on Binge-Like Ethanol Intake. FRONTIERS IN BEHAVIORAL NEUROSCIENCE. 1-12. 2017
- Psychological symptomatology and impaired prepulse inhibition of the startle reflex are associated with cannabis-induced psychosis.. JOURNAL OF PSYCHOPHARMACOLOGY. 1035-1045. 2017
- The Modulation of the Startle Reflex as Predictor of Alcohol Use Disorders in a Sample of Heavy Drinkers: A 4-Year Follow-Up Study.. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 1212-1219. 2017
- The rewarding effects of ethanol are modelated by binge eating of a high-fat diet during adolescence . NEUROPHARMACOLOGY. 219-230. 2017
- Increased Expression of Readthrough Acetylcholinesterase Variants in the Brains of Alzheimer's Disease Patients.. JOURNAL OF ALZHEIMERS DISEASE. 831-841. 2016
- Increased vulnerability to ethanol consumption in adolescent maternal separated mice.. ADDICTION BIOLOGY. 847-858. 2016
- Social defeat in adolescent mice increases vulnerability to alcohol consumption.. ADDICTION BIOLOGY. 87-97. 2016
- Topiramate increases the rewarding properties of cocaine in young-adult mice limiting its clinical usefulness.. PSYCHOPHARMACOLOGY. 3849-3859. 2016
- Differential pharmacological regulation of sensorimotor-gating deficit in CB1 knockout mice and associated neurochemical and histological alterations. NEUROPSYCHOPHARMACOLOGY. 2639-2647. 2015
- Gestational and early postnatal hypothyroidism alters VGluT1 and VGAT bouton distribution in the neocortex and hippocampus, and behavior in rats. FRONTIERS IN NEUROANATOMY. 2015
- Increased vulnerability to ethanol consumption in adolescent maternal separated mice. ADDICTION BIOLOGY. 2015
- Role of CB2 receptors in social and aggressive behavior in male mice. PSYCHOPHARMACOLOGY. 3019-3031. 2015
- Role of cannabinoid CB2 receptor in the reinforcing actions of ethanol 2015. ADDICTION BIOLOGY. 43-55. 2015
- Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain. PAIN. 2001-2012. 2015
- Social defeat in adolescent mice increased the vulnerability for alcohol consumption . ADDICTION BIOLOGY. 1-10. 2015
- Abnormal expression pattern of Notch receptors, ligands, and downstream effectors in the dorsolateral prefrontal cortex and amygdala of suicidal victoms. MOLECULAR NEUROBIOLOGY. 957-965. 2014
- Effects of naltrexone plus topiramate on ethanol self-administration and tyrosine hydroxylase gene expression changes. ADDICTION BIOLOGY. 862-873. 2014
- Role of cannabinoid CB2 receptor in the reinforcing actions of ethanol. ADDICTION BIOLOGY. 2014
- Social defeat in adolescent mice increases vulnerability to alcohol consumption. ADDICTION BIOLOGY. 2014
- Abnormal expression pattern of Notch receptors, ligands and downstream effectors in the dorsolateral prefrontal cortex and amygdala of suicidal victims. MOLECULAR NEUROBIOLOGY. 1-10. 2013
- CB1 cannabinoid receptor-mediated aggressive behavior. NEUROPHARMACOLOGY. 172-180. 2013
- Deletion of CB2 cannabinoid receptors increased voluntary ethanol consumption and ethanol self-administration associated to alterations in tyrosine hydroxylase and mu-opioid receptor in the mice brain. ADDICTION BIOLOGY. 2013
- FKBP5 alterations in the dorsal prefrontal cortex and amygdala of suicide victims . PSYCHONEUROENDOCRINOLOGY. 1251-1258. 2013
- Role of CB2 cannabinoid receptors in the rewarding, reinforcing, and physical effects of nicotine. NEUROPSYCHOPHARMACOLOGY. 2013
- Synergistic action of naltrexone plus topiramate on ethanol self-administration in C57BL/6 mice and tyrosine hydroxylase gene expression changes in the ventral tegmental area. ADDICTION BIOLOGY. 2013
- Cannabinoid CB2 receptor-mediated regulation of impulsive-like behaviour in DBA/2 mice. . BRITISH JOURNAL OF PHARMACOLOGY. 260-273. 2012
- Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine. . NEUROBIOLOGY OF AGING. 4211-42116. 2012
- Pregabalin and topiramate mediated regulation of cognitive and motor impulsivity in DBA/2 mice.. BRITISH JOURNAL OF PHARMACOLOGY. 183-195. 2012
- Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine. NEUROBIOLOGY OF AGING. 1-16. 2010
- Métodos de evaluación de trastornos cognitivos en modelos animales. REVISTA DE NEUROLOGIA. 137-145. 2008
book
- Guía de intervención clínica para el manejo del trastorno por uso de alcohol. UNIVERSIDAD MIGUEL HERNANDEZ. 2021
chapter
- Substance Use Disorders and the Endocannabinoid System: A New Narrative. Handbook of the Biology and Pathology of Mental Disorders. 1-27. 2024
- Farmacología del alcohol e intoxicación aguda. Drogodependencias 4ª ed. 117-129. 2023
- Biomarkers. Comprehensive pharmacology. 693-724. 2022
- Biomarkers. Reference Module in Biomedical Sciences. 1-31. 2021
- Estrés temprano y sus consecuencias en la vida adulta. Neurobiología del Estrés Temprano. Respuesta del estrés durante la programación de la vida temprana.. 89-106. 2020
- Cannabidiol and Cannabis Use Disorders. Cannabis Use Disorders. 31-42. 2018
congress communication
thesis
- REGULACION FARMACOLOGICA DE LA CONDUCTA IMPULSIVA: IMPLICACION DEL RECEPTOR CANNABINOIDE CB2 Y UTILIDAD TERAPEUTICA DE FARMACOS ANTICONVULSIVANTES 2012

presentations

invited conference

VIVO

NAVARRETE RUEDA, FRANCISCO

Positions

Publications

supported publications or other works

selected publications

academic article

book

chapter

congress communication

thesis

presentations

invited conference

Research

principal investigator on

investigator on

Teaching

teaching activities

Service

organizer of event

Contact

full name

Otro

Included in